H. Ghedira (Ariana, Tunisia), L. Chovan (Bratislava-Sloven, Slovakia)
Serum pharmacokinetics of antituberculosis drugs in volunteers
M. A. Zaitseva, M. L. Alexandrova, S. P. Nechiporenko, S. E. Kolbasov (St Petersburg, Russia)
|  |
Express-diagnosing of multidrug resistant bacterial and L-forms of mycobacterium tuberculosis
E. Y. Nosova, O. I. Skotnikova, M. V. Badleeva, K. Y. Galkina, A. M. Moroz, V. M. Mikhailovich, I. R. Dorozhkova (Moscow, Russia)
| |
The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study
Y. Kobashi, T. Matsushima (Kurashiki City, Japan)
| |
Evaluation of prophylactic observations efficacy and the quality of TB treatment using a math model for primarily revealed patients
O. V. Tchijova (Moscow, Russia)
| |
Short course of chemotherapy of multidrug resistant tuberculosis (MDR TB)
V. M. Petrenko, S. A. Cherenko, E. R. Tarasenko (Kiev, Ukraine)
| |
Effect of vitamin A & zinc supplementation on clinical response &nutritional status in patients with tuberculosis getting standard chemotherapy: a double blind, placebo control study in Bangladesh
S. M. A. A. Mamun, P. M. Rahman (Dhaka, Bangladesh)
| |
The effect of anti-inflammatory treatment to the pleural thickening in tuberculosis pleuresy
Z. Karakurt, T. Morali, M. Yavsan, N. Gungor, B. Uskul, H. Turker (Istanbul, Turkey)
| |
In vitro activity of triclosan ( TCN ) and thiolactomycin ( TLM ) against multi-drug-resistant ( MDR ) strains of mycobacterium tuberculosis ( M. tb )
S. P. Vaidya, M. G. Kulkarni, G. V. Koppikar (Mumbai, India)
| |
A study on the clinical efficacy of a combination regimen with azithromycin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis
S. K. Agarwal (Varanasi, India)
| |
Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance
A. M. Skrahina, V. V. Borstchevsky, H. L. Hurevich, L. K. Surkova, A. E. Skrahin, O. M. Zalutskaya (Minsk, Belarus)
| |
Safety and tolerability to long term moxifloxacin treatment in 38 patients with difficult to manage tuberculosis: preliminary data
L. R. Codecasa, M. Ferrarese, V. Penati, C. Lacchini, G. B. Migliori (Milan, Tradate, Italy)
| |
Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR)
D. V. Krasnov, V. A. Krasnov, A. A. Andrenko, N. G. Grischenko, T. G. Beschetniy (Novosibirsk, Russia)
| |
Directly observed therapy versus self administered therapy for patients of new smear positive pulmonary tuberculosis during hospitalisation period
F. Ciftci, E. Bozkanat, O. Deniz, E. Tozkoparan, O. Okutan, A. Ilvan, H. Bilgic, N. Demirci (Istanbul, Ankara, Turkey)
| |
The effects of drug resistance phenotype on proliferation of Mycobacterium tuberculosis
S. M. Mirsaeidi, P. Farnia, F. Mohammadi, M. Kazempour, G. Kameran, M. R. Masjedi, A. A. Velayati (Tehran, Iran)
| |
Antituberculous activity of fiurenizid in vitro and in patients with destructive pulmonary tuberculosis
I. B. Byalik, L. M. Tsygankova, Z. E. Vyalykh, E. R. Tarasenko, V. V. Davidenko (Kiev, Ukraine)
| |
Paradoxical response to adequate antituberculosis treatment
A. M. Skrahina, H. L. Hurevich, J. I. Krivosheeva, T. A. Skrahina, A. F. Belko (Minsk, Belarus)
| |
Urinary N-acetil-beta-glucosaminidase in the evaluation of antituberculous treatment
L. M. Munteanu, M. G. Munteanu, G. M. Gluhovschi, V. M. Tudorache (Timisoara, Romania)
| |
Basic factors, influencing treatment efficacy of patients with newly detected sputum positive destructive lung tuberculosis
V. M. Petrenko, N. A. Litvinenko (Kiev, Ukraine)
| |
Psycho-social variables involved in TB outpatient’s management during the supervision time
C. T. Vartolomei, A. A. Sorete-Arbore (Iasi, Romania)
| |
DOTS strategy - key for the progress in the control of TB; five years of experience in Iasi County
A. Sorete-Arbore, T. Mihaescu (Iasi, Romania)
| |